BIOXCEL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioXcel Therapeutics, Inc.

NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 5, 2023 to file lead plaintiff applications in a securities class action lawsuit against BioXcel Therapeutics, Inc. (NasdaqCM: BTAI), if they purchased the Company’s securities between December 15, 2021 and June 28, 2023, inclusive (the … Read more

Modified starch market size to grow by USD 2,862.71 million from 2022 to 2027; High demand for corn starch to boost the market growth

NEW YORK, Aug. 11, 2023 /PRNewswire/ — The modified starch market size is expected to grow by USD 2,862.71 million during 2022-2027, progressing at a CAGR of 4.36% as per the latest Technavio market research report. North America is estimated to account for 35% of the global market growth during the forecast period. The demand for modified starch in the … Read more

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more

Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Aug. 8, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut against BioXcel Therapeutics, Inc. (“BioXcel”) (NASDAQ: BTAI). The action charges BioXcel with violations of the federal securities … Read more

Repurchases of shares by Concentric AB during week 31, 2023

REDDITCH, England, Aug. 8, 2023 /PRNewswire/ — Between 31 July 2023 and 4 August 2023 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 14,769 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares … Read more

Envista Holdings Corporation Announces Proposed Convertible Senior Notes Offering

BREA, Calif., Aug. 7, 2023 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced its intention to offer, subject to market and other conditions, $435,000,000 in aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of … Read more

Piramal Pharma Limited annonce ses résultats consolidés pour le premier trimestre de l’exercice 2024

MUMBAI, Inde, 6 août 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a annoncé aujourd’hui ses résultats consolidés pour le premier trimestre (T1) clos le 30 juin 2023. Nandini Piramal, Chairperson, Piramal Pharma Limited Faits saillants des résultats financiers consolidés : (En crores INR) Détails T1 Exercice 2024 T1 Exercice 2023 Croissance annuelle T4 Exercice 2023 Croissance trimestrielle … Read more

World’s Most Successful Athletic Fundraiser Pan-Mass Challenge Brings Together Thousands of Cyclists to Raise $70 Million for Cancer Research

The PMC Aims to Exceed $970 Million Raised for Dana-Farber Cancer Institute with Most Ambitious Fundraising Goal to Date  BOSTON, Aug. 5, 2023 /PRNewswire/ — On Saturday, August 5 and Sunday, August 6, the Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, will bring together 6,500 riders and over 3,000 volunteers for its 44th ride. … Read more

Global Connected Healthcare Market Report 2023-2027 & 2032

DUBLIN, Aug. 4, 2023 /PRNewswire/ — The “Connected Healthcare Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global connected healthcare market grew from $100.03 billion in 2022 to $127.53 billion in 2023 at a compound annual growth rate (CAGR) of 27.5%. The connected healthcare market is expected to grow to $345.49 billion … Read more

ACCORD et HIPRA concluent un accord de distribution exclusif pour commercialiser le vaccin COVID-19 (BIMERVAX®) de HIPRA au Royaume-Uni

BIMERVAX® : une dose de rappel d’un vaccin bivalent à base de protéines recombinantes permet d’immuniser les personnes âgées de plus de 16 ans LONDRES et GERONE, Espagne, 4 août 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord) et HIPRA ont annoncé aujourd’hui qu’ils ont conclu un accord de distribution exclusif pour commercialiser le vaccin COVID-19 de HIPRA … Read more